In vivo fate and intracellular trafficking of vaccine delivery systems

Adv Drug Deliv Rev. 2022 Jul:186:114325. doi: 10.1016/j.addr.2022.114325. Epub 2022 May 10.

Abstract

With the pandemic of severe acute respiratory syndrome coronavirus 2, vaccine delivery systems emerged as a core technology for global public health. Given that antigen processing takes place inside the cell, the intracellular delivery and trafficking of a vaccine antigen will contribute to vaccine efficiency. Investigations focusing on the in vivo behavior and intracellular transport of vaccines have improved our understanding of the mechanisms relevant to vaccine delivery systems and facilitated the design of novel potent vaccine platforms. In this review, we cover the intracellular trafficking and in vivo fate of vaccines administered via various routes and delivery systems. To improve immune responses, researchers have used various strategies to modulate vaccine platforms and intracellular trafficking. In addition to progress in vaccine trafficking studies, the challenges and future perspectives for designing next-generation vaccines are discussed.

Keywords: Cellular uptake; Endosomal escape; In vivo fate; Intracellular trafficking; Translation enhancement; Vaccine delivery system.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens
  • COVID-19* / prevention & control
  • Drug Delivery Systems
  • Humans
  • Vaccines*

Substances

  • Antigens
  • Vaccines